Kura Oncology Inc (NASDAQ:KURA)
| 19.45 Delayed Data As of Jul 05 |  +0.95 / +5.14%Today’s Change | 10.41 Today|||52-Week Range 21.29 | +38.93% Year-to-Date |
Latest KURA News | Press Releases
No recent news for Kura Oncology Inc.
Today’s Trading
| Previous close | 18.50 |
| Today’s open | 18.27 |
| Day’s range | 18.27 - 19.46 |
| Volume | 971,029 |
| Average volume (3 months) | 648,726 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | -16.45% |
| Earnings growth (this year) | -10.81% |
| Earnings growth (next 5 years) | +16.24% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VCELVericel Corp | +1.94 | +7.51% |
| MDGLMadrigal Pharmaceuti... | +4.96 | +6.74% |
| AGIOAgios Pharmaceutical... | +2.09 | +8.95% |
| RETAReata Pharmaceutical... | +6.05 | +19.88% |
Data as of 4:00pm ET, 07/05/2022
Financials
| Next reporting date | August 8, 2022 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$130.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
